Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AIM Immunotech
AddedFeb 19, 2024
UpdatedJul 4, 2026
AIM Immunotech

AIM Immunotech

Public

US-based AIM ImmunoTech Inc. pioneers in developing therapeutics for cancer and immune disorders.

HQ
Ocala, FL, US
Founded
1990
Overview
Compare
Employees
Website

AIM ImmunoTech Inc., founded in the United States, is a biopharmaceutical company dedicated to the research and development of innovative therapeutics for cancer and immune-deficiency disorders. The company's core mission is to advance immunology to create a better future for patients suffering from debilitating and life-threatening conditions. AIM ImmunoTech's flagship product, Ampligen®, is an immuno-modulator with broad-spectrum activity, currently being evaluated in clinical studies for various disease areas, including oncology, immune disorders, and viral diseases.

Notable figures associated with AIM ImmunoTech include its experienced leadership team and scientific advisors who bring extensive expertise in immunology and pharmaceutical development. The company has attracted significant investment from both private and institutional investors, enabling it to progress its clinical trials and research initiatives. AIM ImmunoTech's key achievements include successful preclinical and clinical evaluations of Ampligen®, positioning it as a promising therapeutic candidate. The company's impact lies in its potential to offer new treatment options for patients with limited alternatives, thereby contributing to advancements in medical science and patient care.

AIM Immunotech - Similar Companies

Immunome logo

Immunome

INmune Bio logo

INmune Bio

inmunebio.com

Immunomic Therapeutics logo

Immunomic Therapeutics

immunomix.com

Inimmune logo

Inimmune

inimmune.com

Imunon logo

Imunon

imunon.com

ImmunityBio logo

ImmunityBio

immunitybio.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

AmplifyBio logo

AmplifyBio

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Immuneering logo

Immuneering

immuneering.com

Inmagene Biopharmaceuticals logo

Inmagene Biopharmaceuticals

inmagenebio.com

Nantkwest logo

Nantkwest

ImmuneTarget logo

ImmuneTarget

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

AIM Immunotech - Quick Facts

Who are AIM Immunotech's competitors?

Companies similar to AIM Immunotech include Immunome, INmune Bio, Immunomic Therapeutics and Inimmune.

When was AIM Immunotech founded?

AIM Immunotech was founded in 1990.

Where is AIM Immunotech's headquarters located?

AIM Immunotech's headquarters is located in Ocala, FL, US.

How many employees does AIM Immunotech have?

AIM Immunotech has 22 employees as of Feb 6, 2024.

AIM Immunotech - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0000946644
  • ticker: AIM
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research